CBD Life Sciences
Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted
Wellness Needs, Tapping into a Booming $20 Billion
Market
Projected to reach
the $20 billion global mushroom market by 2030, CBDL's entry offers
shareholders a unique opportunity to capitalize on a sector growing
at over 14% annually
Scottsdale, AZ -- October 31, 2024 --
InvestorsHub NewsWire -- CBD Life Sciences Inc. (OTC:
CBDL) sets a new industry standard with its launch of a
high-performance line of mushroom-infused gummies, designed to meet
the surging demand for wellness products in a projected $20 billion
market. Focused on energy, sleep, and sexual wellness, these unique
formulations offer CBDL shareholders and new investors an
unprecedented growth opportunity in an exploding sector.
With an expanding consumer focus on
holistic health and functional ingredients, CBDL's
Rise, Dream, and Bloom Gummies
each bring targeted benefits,
including cognitive enhancement, restful sleep, and boosted
vitality. These products are strategically positioned to address
top wellness priorities, blending potent natural ingredients with
advanced formulation technology. This launch is expected to significantly contribute to
CBDL's revenue stream, enhancing shareholder value and setting the
company apart as an innovator in functional wellness.
Targeted Wellness
Meets Market Demand: Three Powerful Formulations
Rise
Gummies are formulated to
support focus and energy, each containing 500mg of Lion's Mane
Mushroom,
1 microgram of
B12, and
25mg of
Ginseng. This combination
aligns with a growing segment of consumers seeking natural
solutions to boost mental clarity and productivity.
Dream
Gummies provide natural
support for relaxation and sleep, with 500mg of Reishi
Mushroom,
25mg of
Kava,
and 10mg of
5-HTP. With sleep wellness
now a top priority for many, Dream Gummies offer a
non-habit-forming solution to support stress relief and emotional
balance.
Bloom
Gummies offer a targeted
formula for sexual wellness and vitality, incorporating
500mg of Cordyceps
Mushroom along with
Tongkat Ali,
Ginkgo Biloba, Ginseng, L-Arginine, Ashwagandha, and
Maca. This powerful
combination is designed to support libido, energy, and overall
wellness, meeting the needs of consumers prioritizing vitality and
balance.
A Game-Changing
Opportunity for Growth and Profitability
The global mushroom market, projected
to reach $20 billion by
2030, continues to grow as
consumers increasingly value natural wellness products. This trend
puts CBDL in a prime position to capitalize on the expanding
market, with each product tailored to high-demand wellness
categories. By establishing itself early in the functional mushroom space, CBDL not only
strengthens its product lineup but creates multiple revenue streams
that align with future growth.
Furthermore, as CBDL advances in this
sector, its market differentiation promises significant potential
for profit, brand expansion, and sustained shareholder value. With
early adoption into these emerging wellness sectors, CBDL is
creating a scalable pathway for growth, ensuring long - term
profitability and new revenue channels, particularly attractive to
investors.
Why Investors
Should Take Note
This new product line underscores
CBDL's commitment to innovation and market leadership, poised to
drive substantial revenue growth. With the functional gummy market
projected to grow at over 14% annually,
CBDL's unique formulations position
the company as a leader in a niche that aligns perfectly with
evolving consumer preferences.
For existing and potential investors,
CBDL's mushroom gummy line represents an unmatched opportunity for
portfolio growth. The anticipated success of Rise, Dream, and Bloom
Gummies is expected to boost CBDL's market share and generate
heightened interest from strategic retail partners, translating
into higher returns and increased shareholder equity. With its
pioneering approach to wellness, CBDL is dedicated to securing
sustained value for investors by remaining at the forefront of
natural health innovation.
About CBD Life
Sciences, Inc.
CBD Life Sciences, Inc.
(OTC
PINK: CBDL) is a leading innovator in the CBD and wellness
industry, committed to creating high-quality, scientifically backed
products that promote health and well - being. From pain relief to overall wellness, CBD
Life Sciences strives to deliver top-tier
solutions that meet the needs of today's consumers.
Follow our social media for the latest
updates! X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
IR Contact: cbdvaultaz@gmail.com
Forward-Looking
Statements
Except for the historical information
contained herein, the matters discussed in this press release are
forward-looking statements. Actual results may differ materially
from those described in forward-looking statements and are subject
to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s
filings with OTC Markets, which may identify specific factors that
may cause actual results or events to differ materially from those
described in the forward-looking statements.
Safe Harbor
Statement
This release includes forward-looking
statements, which are based on certain assumptions and
reflects management's current
expectations. These forward-looking statements are subject to a
number of risks and uncertainties that could cause actual results
or events to differ materially from current expectations. Some of
these factors include: general global economic conditions; general
industry and market conditions, sector changes and growth rates;
uncertainty as to whether our strategies and business plans will
yield the expected benefits; increasing competition; availability
and cost of capital; the ability to identify and develop and achieve
commercial success; the level of expenditures necessary to maintain
and improve the quality of services; changes in the economy;
changes in laws and regulations, including codes and standards,
intellectual property rights, and tax matters; or other matters not
anticipated; our ability to secure and maintain strategic
relationships and distribution agreements. The Company disclaims
any intention or obligation to update or revise any forward-looking
ability to secure and maintain strategic relationships and
distribution agreements. The Company disclaims any intention or
obligation to update or revise any forward-looking
statements.
Contact
Information
Lisa Nelson
CEO
cbdvaultaz@gmail.com
4802091720